HBIO icon

Harvard Bioscience

6.50 USD
+0.04
0.62%
At close Updated Jun 3, 4:00 PM EDT
1 day
0.62%
5 days
13.44%
1 month
1.56%
3 months
14.84%
6 months
-10.71%
Year to date
-0.31%
1 year
54.39%
5 years
-90.88%
10 years
-82.19%
 

About: Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.

Employees: 339

0
Funds holding %
of 8,072 funds
0
Positive news %
of 3 articles
Price charts implemented using Lightweight Charts™